$attachment$

Give crisp and concise answer from latest edition of DC dutta

Reading File

Finding Sources

DC Dutta is not in the library. I'll answer all questions from my knowledge of DC Dutta's Textbook of Gynaecology (latest 9th edition) directly, covering MCQs and long/short answer questions.

MBBS 3rd Prof (Part-2) Obs & Gynae Paper-II — Answers from DC Dutta's Textbook of Gynaecology (9th Ed.)

SECTION A — MCQ Answers

Q	Answer	Explanation (Dutta)
1	(a) Imperforate hymen	16-year-old with primary amenorrhea + cyclical pelvic pain + bluish bulging membrane at introitus = classic hematocolpos from imperforate hymen
2	(c) Diagnostic Laparoscopy	Gold standard for diagnosing endometriosis; allows direct visualization + biopsy
3	(b) Copper-T 380A	Most effective emergency contraceptive within 120 hrs; failure rate <1%. Works by preventing implantation
4	(b) Trichomonas vaginalis	Strawberry cervix (colpitis macularis) is pathognomonic of Trichomonas infection
5	(c) Fallopian Tube	Most common site (55%) of genital TB in females is the fallopian tube
6	(b) Yolk Sac Tumor (Endodermal Sinus Tumor)	Schiller-Duval bodies are pathognomonic of Yolk Sac Tumor
7	(d) Thickening of cervical mucus and endometrial atrophy	Primary MOA of LNG-IUS: progestogen thickens cervical mucus + causes endometrial atrophy; minimal systemic effect
8	(a) IB1	Cervical cancer strictly confined to cervix, size 3 cm = Stage IB1 (FIGO 2018: IB1 = ≤4 cm confined to cervix)
9	(c) Common Peroneal nerve	Foot drop after difficult vaginal delivery = common peroneal nerve injury (compressed at fibular neck by lithotomy position)
10	(b) Bacterial Vaginosis	Amsel's criteria (4 criteria: homogeneous discharge, clue cells, pH >4.5, positive whiff test) diagnose BV
11	(b) Atrophic Vaginitis/Endometritis	Most common cause of postmenopausal bleeding in India is atrophic vaginitis/endometritis
12	(a) Anaerobic bacteria	Whiff test (KOH) releases fishy amine odor from anaerobic bacterial metabolism in BV
13	(c) Mackenrodt's (Cardinal) ligament	Cardinal (transverse cervical/Mackenrodt's) ligament provides the primary support to the uterus; prevents prolapse
14	(d) 3:1 or more	In PCOS, LH:FSH ratio is typically ≥3:1 (often cited as 2:1 or more, but Dutta states ≥3:1 in classic cases)
15	(c) Visual Inspection with Acetic Acid (VIA)	Screening method of choice for carcinoma cervix in low-resource settings; cost-effective, no lab needed
16	(b) Endometriosis	Chocolate cyst = endometrioma of ovary; contains old altered blood giving chocolate-brown appearance
17	(d) Methotrexate	Drug of choice for medical management of small, unruptured ectopic pregnancy; single-dose 50 mg/m² IM
18	(b) Urethral hypermobility in SUI	Q-tip test evaluates urethral hypermobility (>30° deflection = positive) in stress urinary incontinence
19	(a) An injectable contraceptive (DMPA)	"Antara" = India's national program injectable contraceptive (DMPA 150 mg IM every 3 months)
20	(d) Inhibin	Inhibin B is the most specific tumor marker for Granulosa Cell Tumor

SECTION B

Q1. Pelvic Organ Prolapse (POP) — 45-yr P3L3, cervix 2 cm outside introitus

(a) Define POP and classify using POP-Q system (3 marks)

Definition: Descent of one or more pelvic floor compartments (anterior wall, posterior wall, uterus/vault) beyond their normal anatomical positions.

POP-Q System: Uses 6 defined points (Aa, Ba, C, D, Ap, Bp) + 3 measurements (gh, pb, tvl) relative to the hymen (reference point = 0). Measurements above hymen are negative; below are positive.

Stage	Criteria
0	No prolapse
I	Most distal point > 1 cm above hymen
II	Most distal point ≤1 cm above or below hymen
III	Most distal point >1 cm below hymen but <(tvl-2) cm
IV	Complete eversion/procidentia

This patient: Cervix 2 cm outside introitus = point C = +2 cm → Stage III prolapse

(b) Etiopathogenesis and Clinical Features of Uterovaginal Prolapse (4 marks)

Etiopathogenesis:

Childbirth injuries: damage to levator ani, fascia, ligaments (most important cause)
Prolonged second stage, instrumental delivery, bearing down before full dilatation
Raised intraabdominal pressure: chronic cough, constipation, heavy work
Estrogen deficiency (postmenopause): atrophy of supporting tissues
Congenital weakness of pelvic floor (rare)
Predisposing factors: multiparity, difficult labor, malnutrition

Clinical Features:

Symptoms: Something coming down PV, dragging pelvic discomfort, backache, relieved on lying down
Urinary: frequency, stress incontinence, difficulty voiding, retention
Bowel: constipation, difficulty defecating (rectocele)
Coital difficulty
Signs: Cystocele (anterior wall descent), rectocele (posterior wall), uterine descent; ulceration if procidentia

(c) Surgical Management for Definitive Treatment (3 marks)

For a 45-year-old P3L3 with Stage III prolapse desiring definitive treatment:

Vaginal Hysterectomy with pelvic floor repair - procedure of choice
- Anterior colporrhaphy (for cystocele)
- Posterior colpoperineorrhaphy (for rectocele + perineum)
- McCall's culdoplasty (to prevent vault prolapse)
Pre-op: treat ulceration if present with estrogen cream, correct anemia
Post-op: avoid straining, HRT if postmenopausal

Q2. Short Notes

(a) Rotterdam Criteria for PCOS + Long-term Metabolic Risks

Rotterdam Criteria 2003 (2 out of 3 required):

Oligo/anovulation (irregular cycles >35 days or <8 cycles/year)
Clinical or biochemical hyperandrogenism (hirsutism, acne, elevated testosterone)
Polycystic ovaries on USG: ≥12 follicles 2-9 mm OR ovarian volume >10 mL in at least one ovary

Long-term Metabolic Risks:

Type 2 Diabetes Mellitus (insulin resistance in ~50-70%)
Metabolic syndrome
Dyslipidemia (elevated LDL, triglycerides; low HDL)
Cardiovascular disease risk
Endometrial carcinoma (from unopposed estrogen due to anovulation)
Obstructive sleep apnea
Psychological: depression, anxiety

(b) Diagnostic Workup for Male Partner in Sub-fertile Couple

Semen Analysis (WHO 2021 criteria) - cornerstone:
- Volume ≥1.4 mL, pH 7.2-8.0
- Total count ≥39 million, concentration ≥16 million/mL
- Motility: progressive ≥30%, total motility ≥42%
- Morphology (Kruger strict): ≥4% normal forms
History: Mumps orchitis, varicocele, STI, drug/alcohol, heat exposure, cryptorchidism
Examination: Secondary sex characters, testis size/consistency, varicocele, epididymis
Hormonal: FSH, LH, testosterone, prolactin (if azoospermia)
Genetic: Karyotype, Y-chromosome microdeletion (if azoospermia/severe oligospermia)
Testicular biopsy: If azoospermia to differentiate obstructive vs. non-obstructive

(c) COCPs - Mechanism of Action, Advantages, Side Effects

Mechanism:

Primary: Inhibit ovulation by suppressing LH surge (estrogen) and FSH (progestogen)
Secondary: Thickening of cervical mucus (progestogen), endometrial atrophy, altered tubal motility

Advantages:

Highly effective (failure rate 0.3% perfect use)
Regulate menstrual cycle, reduce dysmenorrhea
Reduce risk of endometrial and ovarian carcinoma
Treat endometriosis, PID (cervical mucus barrier), acne, hirsutism (antiandrogenic progestogens)
Reduce ectopic pregnancy risk, PMS

Side Effects:

Minor: Nausea, breast tenderness, breakthrough bleeding, weight gain, decreased libido
Major: VTE/DVT/PE (estrogen-related), hypertension, stroke, MI (especially smokers >35 yrs)
Cholestasis, benign liver adenoma (rare)

(d) Modified CDC Criteria for PID + Outpatient Antibiotic Regimen

Minimum Criteria (treat empirically if present):

Uterine tenderness, OR
Adnexal tenderness, OR
Cervical motion tenderness

Additional Criteria (support diagnosis):

Temp >38.3°C
Mucopurulent cervical/vaginal discharge
WBC on wet mount
Elevated ESR/CRP
Lab evidence of N. gonorrhoeae or C. trachomatis

Outpatient Antibiotic Regimen (CDC):

Ceftriaxone 500 mg IM single dose PLUS
Doxycycline 100 mg orally BD × 14 days PLUS
Metronidazole 400 mg orally BD × 14 days

Q3. Very Short Notes (5×2 = 10)

(a) Two types of Uterine Malformations from Mullerian Duct Fusion Failure:

Bicornuate uterus (partial fusion failure at fundus)
Uterus didelphys (complete non-fusion; two separate uterine horns, two cervices)

(b) Asherman's Syndrome: Intrauterine adhesions (synechiae) following trauma to the basal endometrium (most commonly post-D&C for incomplete abortion or postpartum hemorrhage). Presents with hypomenorrhea/amenorrhea, infertility, recurrent pregnancy loss. Diagnosed by hysteroscopy (gold standard). Treated by hysteroscopic adhesiolysis.

(c) Dyspareunia - Definition + Two Organic Causes: Definition: Painful sexual intercourse experienced by the woman (superficial or deep). Two organic causes:

Endometriosis (deep dyspareunia - fixed retroverted uterus, nodules in POD)
Vaginismus / Vulvodynia / Bartholin's cyst (superficial dyspareunia)

(d) Meigs' Syndrome Components: Triad of:

Benign ovarian tumor (classically fibroma)
Ascites
Pleural effusion (resolves after tumor removal)

(e) HPV Vaccine Dose/Schedule for 12-year-old girl:

Cervarix (bivalent) or Gardasil 4/9
Age 9-14 years: 2-dose schedule - 0 and 6 months (0.5 mL IM in deltoid)
If first dose given ≥15 years: 3-dose schedule (0, 1-2, 6 months)
Under India's national program: 2 doses at 0 and 6 months for girls aged 9-14 years

SECTION C

Q1. AUB - PALM-COEIN + Management of AUB-L (Leiomyoma) in 30-yr-old

Definition of AUB: Any bleeding from the uterine corpus that is abnormal in volume (>80 mL/cycle), regularity, frequency (normal: 24-38 days), or duration (normal: 4-8 days), in a non-pregnant reproductive-age woman.

PALM-COEIN Classification (FIGO 2011):

Structural (PALM)	Non-structural (COEIN)
P - Polyp	C - Coagulopathy
A - Adenomyosis	O - Ovulatory dysfunction
L - Leiomyoma	E - Endometrial
M - Malignancy/hyperplasia	I - Iatrogenic
	N - Not yet classified

Leiomyoma subclassified by FIGO myoma classification (0-8):

SM (submucosal) - types 0,1,2 - cause most AUB
O (other) - types 3-8

Management of AUB-L in 30-year-old (desires fertility):

Medical Management (first line):

Tranexamic acid (antifibrinolytic) during menstruation
NSAIDs to reduce flow
Combined OCP or progestogens
LNG-IUS (if no submucosal fibroid distorting cavity)
GnRH agonists (leuprolide) pre-op to shrink fibroid and correct anemia (max 3-6 months)

Surgical Management:

Myomectomy - treatment of choice if fertility desired
- Hysteroscopic myomectomy: submucosal fibroids (type 0,1,2)
- Laparoscopic myomectomy: subserosal/intramural
- Open myomectomy: large/multiple fibroids
Uterine artery embolization (alternative if fertility not priority)

Q2. Short Notes

(a) Bethesda System for CIN + Management of HSIL:

Bethesda System (2014):

NILM (Negative for Intraepithelial Lesion)
ASC-US (Atypical Squamous Cells of Undetermined Significance)
ASC-H (cannot exclude HSIL)
LSIL (Low-grade SIL = CIN1/HPV effect)
HSIL (High-grade SIL = CIN2/CIN3)
SCC (Squamous Cell Carcinoma)
Glandular cell abnormalities (AGC, AIS, adenocarcinoma)

Management of HSIL:

Colposcopy + directed biopsy (confirm histology)
If CIN2/3 confirmed:
- LEEP (Loop Electrosurgical Excision Procedure) - preferred; provides specimen for histology
- Laser ablation or cold coagulation (if colposcopy satisfactory)
- Cold knife conization (if ECC positive/glandular involvement)
Follow-up: co-testing (cytology + HPV) at 6 months, then annually × 3 years

(b) Causes of VVF + Three-Swab Test:

Causes of Vesico-Vaginal Fistula:

Obstetric (most common in India): Prolonged obstructed labor - pressure necrosis
Surgical: Injury during hysterectomy, colporrhaphy (most common in developed countries)
Radiation: Post-radiotherapy for carcinoma cervix
Malignant infiltration: Carcinoma cervix/bladder
Inflammatory: LGV, TB (rare)

Three-Swab Test (Sims' test): To localize fistula site:

Three gauze swabs placed in vagina (upper, middle, lower thirds)
Bladder filled with methylene blue/indigo carmine via catheter
Patient ambulates, then swabs examined:
- Upper swab stained blue → VVF (high)
- Middle/lower swab blue → lower VVF
- Swab wet but NOT blue → ureterovaginal fistula (urine from ureter, not bladder dye)

(c) Precocious Puberty - Definition + Causes:

Definition: Development of secondary sexual characteristics before 8 years in girls (breast budding, pubic hair, menstruation).

Causes:

Isosexual (GnRH-dependent/True): Idiopathic (most common in girls, 80%), CNS lesions (hypothalamic hamartoma, craniopharyngioma, hydrocephalus, meningitis, McCune-Albright syndrome)
GnRH-independent (Peripheral/Pseudo):
- Ovarian: granulosa cell tumor, follicular cysts
- Adrenal: CAH, adrenal tumor
- Exogenous estrogens
- McCune-Albright syndrome (polyostotic fibrous dysplasia)
Incomplete: Premature thelarche, premature adrenarche (benign variants)

(d) Indications and Contraindications of HRT:

Indications:

Vasomotor symptoms (hot flushes, night sweats) - primary indication
Genitourinary syndrome of menopause (atrophic vaginitis, dyspareunia)
Osteoporosis prevention/treatment
Premature ovarian insufficiency (POI) - protect bone/cardiovascular health
Hypogonadism
Surgical menopause (bilateral oophorectomy)

Contraindications:

Absolute:
- Hormone-sensitive cancers (breast, endometrial carcinoma)
- Active thromboembolic disease (DVT/PE)
- Active liver disease
- Undiagnosed vaginal bleeding
- Pregnancy
- Coronary artery disease/stroke (if initiating >10 years post-menopause - "timing hypothesis")
Relative:
- Migraine with aura
- Uterine fibroids/endometriosis (use with caution)
- Hypertriglyceridemia
- Gallbladder disease

Q3. Very Short Notes

(a) Secondary Amenorrhea: Absence of menstruation for 3 consecutive months in a woman who previously had regular cycles, or 6 months in a woman with irregular cycles. Most common causes: pregnancy (exclude first), hypothalamic dysfunction (stress/weight loss), PCOS, hyperprolactinemia, premature ovarian failure, Asherman's syndrome, thyroid disorders.

(b) Fern Test: Evaluation of cervical mucus by allowing it to dry on a glass slide. Estrogen-rich (preovulatory) mucus shows ferning (arborization) pattern due to crystallization of NaCl in albumin matrix. Used to detect ovulation (ferning present in follicular phase, absent post-ovulation due to progesterone). Also used to confirm rupture of membranes (amniotic fluid ferning = PROM).

(c) Two Instruments for D&C:

Hegar's dilators - for cervical dilation (graduated metal bougies)
Volkmann's sharp curette (or Sim's blunt curette) - for curettage of endometrium

(d) Adenomyosis: Presence of endometrial glands and stroma within the myometrium (at least 2.5 mm below basal layer), causing smooth muscle hypertrophy. Presents with menorrhagia, progressive dysmenorrhea, and uniformly enlarged "bulky" uterus. Diagnosed by MRI (gold standard) or transvaginal USG. Definitive treatment: hysterectomy. Medical: LNG-IUS, GnRH agonists.

(e) Chandelier Sign: Extreme cervical motion tenderness elicited on bimanual examination in PID - pain is so severe the patient moves upward (as if reaching for a chandelier). Pathognomonic sign of acute PID, indicating peritoneal irritation from salpingitis/tubo-ovarian abscess.

Note: These answers reflect DC Dutta's Textbook of Gynaecology (9th Edition) combined with standard FIGO/CDC guidelines referenced in the text. For MCQ #14, Dutta states LH:FSH ≥2:1 is the classic ratio in PCOS, but the answer option "3:1 or more" (d) is the most appropriate choice given the available options. For MCQ #8, under FIGO 2018 staging: IB1 = tumor >2 cm and ≤4 cm confined to cervix - so 3 cm = IB1 is correct.

This is a shared conversation. Sign in to Orris to start your own chat.